ZL216

N/A

Report date: 2023/03/07 16:49:07
NME

Base Information

Drug NameZL216
Drug Alias NameZL216ZL-216
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionNucleolin degraders
TargetsNucleolin
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHunan University
China Registration ClassN/A

Develop Information

Active CompaniesHunan University
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A